Cargando…

ADAMTS13 conformation is closed in non-immune acquired thrombotic thrombocytopenic purpura of unidentified pathophysiology

Detalles Bibliográficos
Autores principales:	Joly, Bérangère S., Roose, Elien, Coppo, Paul, Vanhoorelbeke, Karen, Veyradier, Agnès
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892849/ https://www.ncbi.nlm.nih.gov/pubmed/35484652 http://dx.doi.org/10.3324/haematol.2022.280768

Ejemplares similares

Diagnosis and follow‐up of thrombotic thrombocytopenic purpura with an automated chemiluminescent ADAMTS13 activity immunoassay
por: Beranger, Nicolas, et al.
Publicado: (2020)

The Specificities of Thrombotic Thrombocytopenic Purpura at Extreme Ages: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2023)

Measuring ADAMTS-13 activity to diagnose thrombotic thrombocytopenic purpura: a novel, fast fiber-optic surface plasmon resonance immunoassay
por: Bonnez, Quintijn, et al.
Publicado: (2023)

Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patients
por: Schelpe, An-Sofie, et al.
Publicado: (2019)

Modifying ADAMTS13 to modulate binding of pathogenic autoantibodies of patients with acquired thrombotic thrombocytopenic purpura
por: Graça, Nuno A. G., et al.
Publicado: (2019)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2018)

Dissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers
por: Hrdinová, Johana, et al.
Publicado: (2021)

Generation of Anti-Murine ADAMTS13 Antibodies and Their Application in a Mouse Model for Acquired Thrombotic Thrombocytopenic Purpura
por: Deforche, Louis, et al.
Publicado: (2016)

Generation and validation of small ADAMTS13 fragments for epitope mapping of anti‐ADAMTS13 autoantibodies in immune‐mediated thrombotic thrombocytopenic purpura
por: Kangro, Kadri, et al.
Publicado: (2020)

ADAMTS13 and Non-ADAMTS13 Biomarkers in Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Bonnez, Quintijn, et al.
Publicado: (2023)

HLA-DRB1*11 is a strong risk factor for acquired thrombotic thrombocytopenic purpura in children
por: Joly, Bérangère S., et al.
Publicado: (2020)

ADAMTS13 conformation and immunoprofiles in Japanese patients with immune-mediated thrombotic thrombocytopenic purpura
por: Sakai, Kazuya, et al.
Publicado: (2022)

More on the use of frontline caplacizumab in immune-mediated thrombotic thrombocytopenic purpura
por: Picod, Adrien, et al.
Publicado: (2022)

Understanding the Health Literacy in Patients With Thrombotic Thrombocytopenic Purpura
por: Pereira, Leydi C. Velasquez, et al.
Publicado: (2020)

Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination
por: Picod, Adrien, et al.
Publicado: (2022)

Recombinant ADAMTS 13 in thrombotic thrombocytopenic purpura
por: Scully, Marie, et al.
Publicado: (2017)

Anti-cysteine/spacer antibodies that open ADAMTS13 are a common feature in iTTP
por: De Waele, Laure, et al.
Publicado: (2021)

Congenital Thrombotic Thrombocytopenic Purpura: Atypical Presentation and New ADAMTS 13 Mutation in a Tunisian Child
por: Borgi, A., et al.
Publicado: (2013)

Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura()
por: Thomas, Mari R., et al.
Publicado: (2015)

Immune-mediated thrombotic thrombocytopenic purpura plasma induces calcium- and IgG-dependent endothelial activation: correlations with disease severity
por: Tellier, Edwige, et al.
Publicado: (2022)

Prasugrel and Acquired Thrombotic Thrombocytopenic Purpura Associated with ADAMTS13 Activity Deficiency
por: Lopez, Yanet Parodis, et al.
Publicado: (2016)

Anti-ADAMTS13 Antibodies and a Novel Heterozygous p.R1177Q Mutation in a Case of Pregnancy-Onset Immune-Mediated Thrombotic Thrombocytopenic Purpura
por: Roose, Elien, et al.
Publicado: (2018)

Predictive Scores for Early Identification of Immune-Mediated Thrombotic Thrombocytopenic Purpura: Room for Improvement?
por: Joseph, Adrien, et al.
Publicado: (2022)

Thrombotic Thrombocytopenic Purpura: Pathophysiology, Diagnosis, and Management
por: Sukumar, Senthil, et al.
Publicado: (2021)

Thrombotic Thrombocytopenic Purpura in Black People: Impact of Ethnicity on Survival and Genetic Risk Factors
por: Martino, Suella, et al.
Publicado: (2016)

Incidence of obstetrical thrombotic thrombocytopenic purpura in a retrospective study within thrombocytopenic pregnant women. A difficult diagnosis and a treatable disease
por: Delmas, Yahsou, et al.
Publicado: (2015)

Severe HELLP syndrome masquerading as thrombocytopenic thrombotic purpura: a case report
por: Mousseaux, Cyril, et al.
Publicado: (2020)

Ribosomal and Immune Transcripts Associate with Relapse in Acquired ADAMTS13-Deficient Thrombotic Thrombocytopenic Purpura
por: Edgar, Contessa E., et al.
Publicado: (2015)

Congenital Thrombotic Thrombocytopenic Purpura With a Novel ADAMTS13 Gene Mutation
por: Rashid, Anila, et al.
Publicado: (2020)

Acquired Idiopathic ADAMTS13 Activity Deficient Thrombotic Thrombocytopenic Purpura in a Population from Japan
por: Matsumoto, Masanori, et al.
Publicado: (2012)

Thrombotic thrombocytopenic purpura: Toward targeted therapy and precision medicine
por: Coppo, Paul, et al.
Publicado: (2018)

Thrombotic thrombocytopenic purpura
por: Knöbl, Paul
Publicado: (2018)

Risk Factors for Autoimmune Diseases Development After Thrombotic Thrombocytopenic Purpura
por: Roriz, Mélanie, et al.
Publicado: (2015)

ADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpura
por: Manea, Minola, et al.
Publicado: (2006)

Relapsing thrombotic thrombocytopenic purpura with low ADAMTS13 antigen levels: An indication for splenectomy?
por: Lombardi, Anna Maria, et al.
Publicado: (2019)

Immune thrombotic thrombocytopenic purpura: Personalized therapy using ADAMTS‐13 activity and autoantibodies
por: Palandri, Francesca, et al.
Publicado: (2021)

Identification of a novel genetic locus associated with immune-mediated thrombotic thrombocytopenic purpura
por: Stubbs, Matthew J., et al.
Publicado: (2021)

Preemptive cyclosporin A in immune‐mediated thrombotic thrombocytopenic purpura
por: Comparon, Celine, et al.
Publicado: (2022)

Concentration and Subclass Distribution of Anti-ADAMTS13 IgG Autoantibodies in Different Stages of Acquired Idiopathic Thrombotic Thrombocytopenic Purpura
por: Sinkovits, György, et al.
Publicado: (2018)

Caplacizumab use for immune thrombotic thrombocytopenic purpura: the Milan thrombotic thrombocytopenic purpura registry
por: Agosti, Pasquale, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_468d8qkgilsohe9o0c6mfgabpv